Showing posts with label Lenvima (lenvatinib) for Differentiated Thyroid Cancer. Show all posts
Showing posts with label Lenvima (lenvatinib) for Differentiated Thyroid Cancer. Show all posts
Monday, August 3, 2015

FDA Approves Lenvima (lenvatinib) for Differentiated Thyroid Cancer

›
LENVIMA, a kinase inhibitor, is the mesylate salt of lenvatinib. Its chemical name is 4- [3chloro-4-(N’-cyclopropylureido)phenox...